SEARCH BLOG


WIPO & Pharma Team-Up with Pat-INFORMED Program

The Patent Information Initiative for Medicines (Pat-INFORMED) aims to create a common platform or database of key medicine patents & information, accessible to health professionals worldwide. 
Earlier this month, the World Intellectual Property Organization (WIPO), in partnership with the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), s… https://www.globalpatentsolutions.com/blog/2017/10/wipo-pharma-team-pat-informed-program/

FluMist Flop: CDC Finds Inventive Vaccine Ineffective

The CDC has recently withdrawn its recommendation for the FluMist, leaving thousands of children and adults with only one option: the shot. 
Flu season is just around the corner, and the Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics have withdrawn their recommendations for the FluM… https://www.globalpatentsolutions.com/blog/2016/09/flumist-flop-cdc-findsinventive-vaccine-ineffective/

Mylan Pharmaceuticals Under Fire for EpiPen Price Jump

Mylan Pharmaceuticals is catching a lot of heat after raising the price of its EpiPen by over 400%.
Mylan Pharmaceuticals is catching a lot of heat after raising the price of its EpiPen by over 400% in the last few years.  Since acquiring the injectable allergy medicine in 2007,… https://www.globalpatentsolutions.com/blog/2016/08/mylan-pharmaceuticals-under-fire-epipen-price-jump/

Pharma Patents & The Battle of Brand V. Generic

The U.S. has seen a significant shift from brand-name prescription drugs to generics.
With a number of big brand-name drugs slated to lose patents this year, generic manufacturers are eager to push their products to market... And consumers are just as eager to get … https://www.globalpatentsolutions.com/blog/2016/08/pharma-patents-battle-brand-v-generic/

Friend or Foe? Companies Settle Up With Patent Rivals

According to Unified Patents' 1st Half 2016 Patent Dispute Report, the numbers for litigation are down.
According to Unified Patents' 1st Half 2016 Patent Dispute Report, the numbers for litigation are down.  Records show that the number of patent cases has decreased in the last hal… https://www.globalpatentsolutions.com/blog/2016/07/friend-or-foe-companies-settle-patent-rivals/

GSK Announces New "Graduated" Approach to Patents

GlaxoSmithKline recently made the shocking announcement that it will no longer seek patents for pharmaceuticals in developing and other low-income countries.
GlaxoSmithKline recently made the shocking announcement that it will no longer seek patents for pharmaceuticals in developing and other low-income countries.  In a recent press r… https://www.globalpatentsolutions.com/blog/2016/04/gsk-announces-new-graduated-approach-patents/

Senate HELPs Promote Innovation in Medicine

Earlier this month, the Health, Education, Labor and Pensions (HELP) committee held the last of three sessions to discuss a series of bills related to fostering innovation in medicine.
Earlier this month, the Health, Education, Labor and Pensions (HELP) committee held the last of three sessions to discuss a series of bills related to fostering innovation in medic… https://www.globalpatentsolutions.com/blog/2016/04/senate-helps-promote-innovation-medicine/

Pfizer Settles Seven Year Lawsuit with $784 Million

Just recently, Pfizer announced that its Wyeth unit will pay nearly $785 million to settle a long-standing lawsuit regarding its heartburn drug, Protonix.
  Just recently, Pfizer announced that its Wyeth unit will pay nearly $785 million to settle a long-standing lawsuit regarding its heartburn drug, Protonix.   Wyeth first came … https://www.globalpatentsolutions.com/blog/2016/03/pfizer-settles-seven-year-lawsuit-784-million/

UK Continues to Fight Dementia with Research and Innovation

UK continues to battle dementia with innovative global developments.
In 2014, at an industry conference in London, UK Prime Minister David Cameron announced a new agenda aimed at fighting "one of the greatest enemies of humanity," dementia.  Here, … https://www.globalpatentsolutions.com/blog/2016/01/uk-continues-fight-dementia-research-and-innovation/

WTO Extends Waiver on Patents for LDCs

The World Trade Organization recently decided to extend a waiver on patents for pharmaceutical products for Least-Developed Country members (LDC).
The WTO Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreed to an extension of the pharmaceutical IP waiver for LDCs on Friday, allowing members to av… https://www.globalpatentsolutions.com/blog/2015/11/wto-extends-waiver-patents-ldcs/

Big Pharma Pushes for Controversial Patent Reform

Big brand pharmaceutical companies are pushing for patent reform that could prove taxing on generic drug makers and consumers. 
Big brand pharmaceutical companies are pushing for patent reform that could prove taxing on generic drug makers and consumers.    Currently, the process of Inter Partes Revi… https://www.globalpatentsolutions.com/blog/2015/09/big-pharma-pushes-controversial-patent-reform/

New Medical Technology Puts Human Organs-on-Chips

Researchers at Harvard University’s Wyss Institute have created a new technology that could help save animals from medical testing.
Researchers at Harvard University’s Wyss Institute have created a new technology that could help save animals from medical testing. Each year, millions of animal lives are lost… https://www.globalpatentsolutions.com/blog/2015/06/new-medical-technology-puts-human-organs-chips/

Education, Innovation and the Future of Medicine

Medical schools across the country are working innovation into their curriculum, creating new real-life experiences for their doctors-in-training.
Medical schools across the country are working innovation into their curriculum, creating new real-life experiences for their doctors-in-training. Arizona’s Mayo Medical Schoo… https://www.globalpatentsolutions.com/blog/2015/02/education-innovation-and-future-medicine/

Nokia Sensing XCHALLENGE Announces Grand Prize Winner

The Nokia Sensing XCHALLENGE is a competition focused on the development of hardware sensors and software sensing technology for healthcare.
The Nokia Sensing XCHALLENGE is a competition focused on the development of hardware sensors and software sensing technology for healthcare.  With a global reach and over $2.25 mi… https://www.globalpatentsolutions.com/blog/2014/11/nokia-sensing-xchallenge-announces-grand-prize-winner/

CDC Patents Ebola Virus

Rumors are stirring that the US government would profit from a potential outbreak because of a patent that it holds on the Ebola virus.
Thomas Eric Duncan, the Liberian man diagnosed with Ebola at a hospital in Texas, passed away on Wednesday leaving many with questions of what will happen next with the virus. … https://www.globalpatentsolutions.com/blog/2014/10/cdc-patents-ebola-virus/

World's Youngest Innovators: Two Whiz Kids to Watch

Ten-year-old inventor Adeeb Al Blooshi and 17-year-old Jack Andraka are on the fast track to success.
Ten-year-old inventor Adeeb Al Blooshi is on the fast track to success, holding seven patents and more than 100 certificates and awards for his inventions. Named as one of the … https://www.globalpatentsolutions.com/blog/2014/08/worlds-youngest-innovators-two-whiz-kids-watch/

ASU and Phoenix Children’s Hospital Use 3D Tech for Cardiac Print Lab

ASU engineers and Phoenix Children’s Hospital have come together to develop a realistic cardiac print lab.
ASU engineers and Phoenix Children’s Hospital have come together to develop a realistic cardiac print lab – a library of hearts -using a combination of medical imaging and 3D tech… https://www.globalpatentsolutions.com/blog/2014/08/asu-and-phoenix-childrens-hospital-use-3d-tech-cardiac-print-lab/

New Cure for Hepatitis C: Patent Litigation & High Price

A new cure for hepatitis C is causing controversy with its $84,000 price and string of patent disputes.
A new cure for hepatitis C is causing controversy with its $84,000 price tag for 12 weeks of treatment.  Gilead Sciences Inc.’s new drug, Sovaldi, may cost roughly $1,000 per pill… https://www.globalpatentsolutions.com/blog/2014/07/new-cure-hepatitis-c-patent-litigation-high-price/

Antibiotic Resistance, Patents, and A Global Health Plan

With antibiotics now available to lower-income countries, the rate at which bacteria are evolving is rapidly increasing.
As global antibiotic use continues to rise, so does the number of drug-resistant bacteria.  Studies by the Center for Disease Dynamics, Economics & Policy (CDDEP) and Princeton Un… https://www.globalpatentsolutions.com/blog/2014/07/antibiotic-resistance-patents-and-global-health-plan/

Latest Posts

Posts By Category


RECEIVE A SYNOPSIS OF OUR STAFF BIOGRAPHIES




DOWNLOAD WHITEPAPERS